| 摘要 |
AGENT FOR THERAPY The invention includes a novel therapeutic agent comprising a specified peptide derivative for use in the prevention or treatment of haemorrhagic conditions associated with acute non-lymphocytic leukaemia or its therapy, the use of the peptide derivative in the manufacture of a medicament for the prevention or treatment of said haemorrhagic conditions, as well as a method of prevention or treatment of said haemorrhagic conditions using the peptide derivative.
|
